GEN - Genetic Engineering and Biotechnology News

Cosmo Pharma Eyes 2027 NDA for Baldness Candidate After Positive Phase III 12-Month Data

Cosmo Pharmaceuticals says it plans to file for FDA approval of its androgenetic alopecia (AGA) candidate clascoterone 5% ...
Morningstar

Cosmo Debuts New Explorer Clip Delivering a Smart Solution to Nationwide School Phone Bans

DENVER, Jan. 6, 2026 /PRNewswire/ -- Cosmo, a leader in purpose-built family technology, today announced the launch of its all-new Explorer Clip, a colorful and clippable companion case for the ...
The Globe and Mail

Cosmo Announces Breakthrough Phase III Topline Results from Scalp 1 and Scalp 2 for Clascoterone 5% Solution in Male Hair Loss, Showing up to 539% Relative Improvement in ...

Dublin, Ireland--(Newsfile Corp. - December 3, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN), a global leader in AI-powered healthcare and specialty pharma, today announced compelling topline results ...
Longview News-Journal

Hollyland Unveils Cosmo C2: A Challenge-solving Solution for Multi-Camera Broadcasting and EFP

SHENZHEN, China, Feb. 13, 2025 /PRNewswire/ -- On February 13, Hollyland, a leading provider of professional wireless intercom solutions, unveiled its latest innovation, the Cosmo C2. This new product ...